MedKoo Biosciences, Inc.
Tel:   +1-919-636-5577    Fax:   +1-919-980-4831    Email:   sales@medkoo.com
Search
Login Register
Search
MedKoo Cat#: 525857 | Name: S1P1-IN-Ex26
Featured New

Description:

WARNING: This product is for research use only, not for human or veterinary use.

S1P1-IN-Ex26 is a novel potent and selective S1P1 receptor antagonist.

Chemical Structure

S1P1-IN-Ex26
S1P1-IN-Ex26
CAS#1233332-37-0

Theoretical Analysis

MedKoo Cat#: 525857

Name: S1P1-IN-Ex26

CAS#: 1233332-37-0

Chemical Formula: C28H28ClFN2O3

Exact Mass: 494.1772

Molecular Weight: 494.99

Elemental Analysis: C, 67.94; H, 5.70; Cl, 7.16; F, 3.84; N, 5.66; O, 9.70

Price and Availability

Size Price Availability Quantity
100mg USD 1,250.00 2 Weeks
200mg USD 1,950.00 2 Weeks
500mg USD 2,950.00 2 Weeks
1g USD 4,650.00 2 Weeks
Bulk Inquiry
Buy Now
Add to Cart
Related CAS #
No Data
Synonym
S1P1-IN-Ex26
IUPAC/Chemical Name
1-[[[5'-[[1-(4-Chloro-3-methylphenyl)ethyl]amino]-2'-fluoro-3,5-dimethyl[1,1'-biphenyl]-4-yl]carbonyl]amino]-cyclopropanecarboxylic acid
InChi Key
YVHNBORUVLWCKF-UHFFFAOYSA-N
InChi Code
InChI=1S/C28H28ClFN2O3/c1-15-11-19(5-7-23(15)29)18(4)31-21-6-8-24(30)22(14-21)20-12-16(2)25(17(3)13-20)26(33)32-28(9-10-28)27(34)35/h5-8,11-14,18,31H,9-10H2,1-4H3,(H,32,33)(H,34,35)
SMILES Code
O=C(C1(NC(C2=C(C)C=C(C3=CC(NC(C4=CC=C(Cl)C(C)=C4)C)=CC=C3F)C=C2C)=O)CC1)O
Appearance
Solid powder
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
Soluble in DMSO
Shelf Life
>2 years if stored properly
Drug Formulation
This drug may be formulated in DMSO
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.9001
More Info

Preparing Stock Solutions

The following data is based on the product molecular weight 494.99 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
1: Kawai H, Osawa Y, Matsuda M, Tsunoda T, Yanagida K, Hishikawa D, Okawara M, Sakamoto Y, Shimagaki T, Tsutsui Y, Yoshida Y, Yoshikawa S, Hashi K, Doi H, Mori T, Yamazoe T, Yoshio S, Sugiyama M, Okuzaki D, Komatsu H, Inui A, Tamura-Nakano M, Oyama C, Shindou H, Kusano H, Kage M, Ikegami T, Yanaga K, Kanto T. Sphingosine-1-phosphate promotes tumor development and liver fibrosis in mouse model of congestive hepatopathy. Hepatology. 2022 Jul;76(1):112-125. doi: 10.1002/hep.32256. Epub 2021 Dec 22. PMID: 34855990. 2: Bassila C, Kluck GEG, Thyagarajan N, Chathely KM, Gonzalez L, Trigatti BL. Ligand-dependent interactions between SR-B1 and S1PR1 in macrophages and atherosclerotic plaques. J Lipid Res. 2024 May;65(5):100541. doi: 10.1016/j.jlr.2024.100541. Epub 2024 Apr 5. PMID: 38583587; PMCID: PMC11087725. 3: Zhang FF, Terry MB, Hou L, Chen J, Lissowska J, Yeager M, Zatonski W, Chanock S, Morabia A, Chow WH. Genetic polymorphisms in folate metabolism and the risk of stomach cancer. Cancer Epidemiol Biomarkers Prev. 2007 Jan;16(1):115-21. doi: 10.1158/1055-9965.EPI-06-0513. PMID: 17220339. 4: Teijaro JR, Studer S, Leaf N, Kiosses WB, Nguyen N, Matsuki K, Negishi H, Taniguchi T, Oldstone MB, Rosen H. S1PR1-mediated IFNAR1 degradation modulates plasmacytoid dendritic cell interferon-α autoamplification. Proc Natl Acad Sci U S A. 2016 Feb 2;113(5):1351-6. doi: 10.1073/pnas.1525356113. Epub 2016 Jan 19. PMID: 26787880; PMCID: PMC4747766. 5: Shen M, Lan Q, Zhang L, Chanock S, Li G, Vermeulen R, Rappaport SM, Guo W, Hayes RB, Linet M, Yin S, Yeager M, Welch R, Forrest MS, Rothman N, Smith MT. Polymorphisms in genes involved in DNA double-strand break repair pathway and susceptibility to benzene-induced hematotoxicity. Carcinogenesis. 2006 Oct;27(10):2083-9. doi: 10.1093/carcin/bgl061. Epub 2006 May 25. PMID: 16728435. 6: Deveci A, Hasna J, Bouron A. Inhibition of store-operated calcium channels by N-arachidonoyl glycine (NAGly): no evidence for the involvement of lipid-sensing G protein coupled receptors. Sci Rep. 2020 Feb 14;10(1):2649. doi: 10.1038/s41598-020-59565-4. PMID: 32060392; PMCID: PMC7021695. 7: Moore LE, Hung R, Karami S, Boffetta P, Berndt S, Hsu CC, Zaridze D, Janout V, Kollarova H, Bencko V, Navratilova M, Szeszenia-Dabrowska N, Mates D, Mukeria A, Holcatova I, Yeager M, Chanock S, Garcia-Closas M, Rothman N, Chow WH, Brennan P. Folate metabolism genes, vegetable intake and renal cancer risk in central Europe. Int J Cancer. 2008 Apr 15;122(8):1710-5. doi: 10.1002/ijc.23318. PMID: 18098291. 8: Kwakyi E, Nartey ET, Otabil MK, Asiedu-Gyekye I, Ahorhorlu SY, Bioma V, Kudzi W. A descriptive study of the single-nucleotide polymorphisms known to affect the Tacrolimus trough concentration per dose, among a population of kidney failure patients in a tertiary hospital in Ghana. BMC Res Notes. 2024 Jul 29;17(1):210. doi: 10.1186/s13104-024-06868-8. PMID: 39080672; PMCID: PMC11288130. 9: Lim U, Wang SS, Hartge P, Cozen W, Kelemen LE, Chanock S, Davis S, Blair A, Schenk M, Rothman N, Lan Q. Gene-nutrient interactions among determinants of folate and one-carbon metabolism on the risk of non-Hodgkin lymphoma: NCI-SEER case-control study. Blood. 2007 Apr 1;109(7):3050-9. doi: 10.1182/blood-2006-07-034330. PMID: 17119116; PMCID: PMC1852210. 10: Das A, Balan S, Mathew A, Radhakrishnan V, Banerjee M, Radhakrishnan K. Corpora amylacea deposition in the hippocampus of patients with mesial temporal lobe epilepsy: A new role for an old gene? Indian J Hum Genet. 2011 May;17 Suppl 1(Suppl 1):S41-7. doi: 10.4103/0971-6866.80358. PMID: 21747587; PMCID: PMC3125046.